Showing results (1001-1010 of 1,017) with videos related to

Sort By:
Pageof 102
Biorxiv : the Preprint Server for Biology|February 16, 2022
Vaccine Protection Against the SARS-CoV-2 Omicron Variant in MacaquesAbishek Chandrashekar, Jingyou Yu, Katherine McMahan, et al.
Cell|April 15, 2022
Vaccine protection against the SARS-CoV-2 Omicron variant in macaquesAbishek Chandrashekar, Jingyou Yu, Katherine McMahan, et al.
Scientific Reports|July 15, 2016
New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infectionsMartin McPhillie, Ying Zhou, Kamal El Bissati, et al.
Applied Optics|June 17, 2006
Wide-field Fizeau imaging telescope: experimental resultsR L Kendrick, Jean-Noel Aubrun, Ray Bell, et al.
Scientific Reports|April 7, 2020
Author Correction: New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infectionsMartin McPhillie, Ying Zhou, Kamal El Bissati, et al.
Molecules (Basel, Switzerland)|October 23, 2021
T3P-Promoted Synthesis of a Series of 2-Aryl-3-phenyl-2,3-dihydro-4<i>H</i>-pyrido[3,2-<i>e</i>][1,3]thiazin-4-ones and Their Activity against the Kinetoplastid Parasite <i>Trypanosoma brucei</i>Lee J Silverberg, Tapas K Mal, Carlos N Pacheco, et al.
Acta Neuropathologica|June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytomaMaja Krech, Amos Muench, Daniel Teichmann, et al.
Journal of Medicinal Chemistry|May 19, 2018
Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2Tom D Heightman, Valerio Berdini, Hannah Braithwaite, et al.
Frontiers in Cellular and Infection Microbiology|July 7, 2020
Potent Tetrahydroquinolone Eliminates Apicomplexan ParasitesMartin J McPhillie, Ying Zhou, Mark R Hickman, et al.
Journal of Medicinal Chemistry|August 13, 2021
Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2Tom D Heightman, Valerio Berdini, Luke Bevan, et al.
Pageof 102